LISA RIVERA: Open Payments
NPI 1093146391 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 5 payments from 5 companies in 2025. Trend: 2023 $641 · 2024 $1,429 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $134 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $48 |
Products named: INGREZZA, FANAPT, REXULTI, Wegovy.
Industry payments across NY — which companies pay providers there.
